Search results

From Self-sufficiency
Jump to: navigation, search
  • ...'' ({{pron-en|ˈklɔrəkwɪn}}) is a [[4-aminoquinoline]] drug used in the treatment or prevention of [[malaria]]. ...rug. It was introduced into clinical practice in 1947 for the prophylactic treatment of malaria.<ref>http://www.cdc.gov/malaria/history/index.htm#chloroquine</r
    16 KB (2,187 words) - 15:41, 27 September 2010
  • ...antibiotic]] effective against ''[[Mycobacterium tuberculosis]]''. For the treatment of tuberculosis, it is classified as a second line drug, i.e. its use is on ...ve against other bacteria as well, cycloserine is not commonly used in the treatment of infections other than tuberculosis.
    5 KB (602 words) - 15:44, 27 September 2010
  • ...|title= A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression|journal=Archives of General Psychiatry |volume ...6395307 |doi=10.1038/sj.npp.1300994}}</ref> and [[heroin]] [[Substance use disorder|addiction]].<ref name="jovaisa">{{Cite journal|author=Jovaisa T, Laurinenas
    69 KB (9,697 words) - 20:01, 24 September 2010
  • In the adult population, ciprofloxacin is limited to the treatment of proven bacterial infections such as: ...Randomized, Double-Blind, Placebo-Controlled Study Of Antibiotics For The Treatment Of Category Iiib Chronic Pelvic Pain Syndrome In Men |url=http://www.prosta
    88 KB (11,930 words) - 15:46, 27 September 2010
  • ...ons), [[bulimia nervosa]], [[panic disorder]] and [[premenstrual dysphoric disorder]].<ref name="RxList">{{cite web | url = http://www.rxlist.com/cgi/generic/f ...x of generic drugs onto the market. Prozac was rebranded "Sarafem" for the treatment of [[PMDD]] in an attempt to stem the post-patent decrease in Eli Lilly's s
    52 KB (7,168 words) - 15:47, 27 September 2010
  • ...the [[clinic]]al [[therapy|treatment]] of the following [[medical disorder|disorder]]s: * [[Preeclampsia]] and [[eclampsia]] or [[hypertensive disorder of pregnancy]] (HDP)
    8 KB (905 words) - 09:56, 20 September 2010
  • ..."The History of Levodopa as it Pertains to Parkinson's disease," Movement Disorder Society’s 10th International Congress of Parkinson's Disease and Movement ...in the prefrontal cortex are thought to contribute to [[attention deficit disorder]]. It has been found that D1 receptors<ref name="Inhibitorydopamine">{{cite
    48 KB (6,470 words) - 15:48, 27 September 2010
  • ...ake oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an [[Addison's disease|Addisonian crisis]]. It may be used topi * [[Posttraumatic stress disorder]]
    41 KB (5,644 words) - 15:50, 27 September 2010
  • ...NS) to relieve [[pain]]. Morphine has a high potential for [[Substance use disorder|addiction]]; [[drug tolerance|tolerance]] and [[psychological]] [[substance ...ublic by Sertürner and Company in 1817 as an [[analgesic]], and also as a treatment for opium and alcohol addiction. Commercial production began in Darmstadt,
    87 KB (12,376 words) - 15:51, 27 September 2010
  • ...dical procedures (such as [[endoscopy|endoscopies]]) to reduce tension and anxiety, and in some surgical procedures to induce [[amnesia]].<ref name="PubChem"> ...ple, forms of [[paresis]]. It is also the first line of defense for a rare disorder called [[stiff-person syndrome]].<ref name="RXL.Indications">{{cite web | d
    78 KB (10,295 words) - 15:51, 27 September 2010
  • ...cially indicated for severe insomnia and other severe or disabling [[sleep disorder]]s. The prescribing guidelines in the UK limit the prescribing of hypnotics
    45 KB (6,129 words) - 21:16, 19 September 2010
  • ...e particularly toxic to children, causing potentially permanent [[learning disorder|learning]] and behavior disorders. Symptoms include abdominal pain, headac Diagnosis and treatment of lead exposure are based on blood lead level (the amount of lead in the b
    90 KB (13,109 words) - 20:36, 20 September 2010
  • ...e generally named after the [[physician]] or [[surgeon]] who described the treatment. ! Letter !! Treatment !! Name !! Specialty !! Description !! Reference/External link
    4 KB (444 words) - 20:05, 21 September 2010
  • ...ed in detoxification, anxiety control therapy, ADHD therapy, and for sleep disorder control.<ref>http://www.wisegeek.com/what-is-lymphatic-drainage.htm{{MEDRS| ...om/cgi/issue_pdf/admin_pdf/1/3037.pdf{{MEDRS|date=August 2010}}</ref> This treatment was popular in Italy in the 1960s and 1970s.<ref name=pmid5517785>{{cite jo
    2 KB (334 words) - 20:26, 21 September 2010
  • | pregnancy_category = Benefit of treatment may outweigh risk to fetus. Risk of [[teratogenicity]] greater if more than ...A]] [[Analogue (chemistry)|analogue]]. It was originally developed for the treatment of [[epilepsy]], and currently, gabapentin is widely used to relieve [[pain
    30 KB (4,025 words) - 21:06, 21 September 2010
  • ...ace-time perception; alteration of visual, auditory, and olfactory senses; anxiety; disorientation; fatigue; and [[Health_issues_and_the_effects_of_cannabis#A ...ttore L, ''et al.'' |title=Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse |journal=J. Neurosci. |volume=27 |issue=21 |pages=5615–
    50 KB (6,686 words) - 21:09, 21 September 2010
  • ...has been reported that sex can be reversed in ''Cannabis'' using chemical treatment.<ref name = "mohanram1982">Mohan Ram, H. Y., and R. Sett. 1982. Induction o ...trospection]] and [[metacognition]] have been reported, amongst cases of [[anxiety]] and [[paranoia]].<ref name = "erowid.org">http://www.erowid.org/plants/ca
    76 KB (10,798 words) - 21:10, 21 September 2010
  • ...stic and Statistical Manual of Mental Disorders]] (DSM-IV). Nevertheless, treatment options have been made available for the rehabilitation of individuals expe ...hors have stated the clear implications of these findings, indicating that treatment for heavy marijuana users should target these two specific beliefs.
    46 KB (6,708 words) - 21:10, 21 September 2010
  • ...ref><ref>Copeland, J (2004). Developments in the treatment of cannabis use disorder. ''Current Opinion in Psychiatry'' 17, 2114-2121</ref> disorder and related issues: a clinician’s guide'', National Cannabis Prevention a
    20 KB (2,835 words) - 21:11, 21 September 2010
  • ...ut of conditions running from [[multiple sclerosis]] to [[Major depressive disorder|depression]]. Synthesized [[cannabinoids]] are also sold as prescription dr ...everal studies to be [[dual diagnosis|correlated with the development]] of anxiety, psychosis, and depression.<ref name="pmid=15574485">{{cite journal | autho
    72 KB (10,341 words) - 21:11, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)